Q3 FY26 · Ended Jun 30, 2026 · View SEC filing
Sales grew, but costs grew faster
Revenue rose 5.4% but operating costs rose 8.4%; the filing blames tariffs, labor and quality remediation.
For investorsWhat has to go right for BD's margin to recover
For foundersPlace the device, sell the refills: BD's hospital playbook
Medical Essentials alone earned $617M against $663M company-wide, because corporate costs, amortization and separation items sit in between.
Net income fell to $377M from $574M, yet continuing operations earned the same as a year earlier.
Large non-cash charges put operating cash flow of $776M well above net income, and capital spending stayed light.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes Becton Dickinson from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
